Inducible T cell costimulatory (ICOS) receptor agonist, feladilimab (FE), alone and in combination (combo) with pembrolizumab (PE): results from INDUCE-1 relapsed/refractory (R/R) melanoma expansion cohorts (EC)
Feladilimab;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Inducible T cell costimulatory (ICOS) receptor agonist, feladilimab (FE), alone and in combination (combo) with pembrolizumab (PE): results from INDUCE-1 relapsed/refractory (R/R) melanoma expansion cohorts (EC) ### Output: Feladilimab;Pembrolizumab